Online inquiry

IVTScrip™ mRNA-Human AGPAT6, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK18312MR)

This product GTTS-WK18312MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & N1-Methylpseudo-UTP. It ecodes the AGPAT6 protein. This product can be used in Mitotic fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_178819.4
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 137964
UniProt ID Q2TU73
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AGPAT6, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) (GTTS-WK18312MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK1184MR IVTScrip™ mRNA-Human CHST8, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA CHST8
GTTS-WK3301MR IVTScrip™ mRNA-Human Intestinal Alkaline Phosphatase, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA Intestinal Alkaline Phosphatase
GTTS-WK6994MR IVTScrip™ mRNA-Human CD13, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA CD13
GTTS-WK16017MR IVTScrip™ mRNA-Human ALG6, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ALG6
GTTS-WK26420MR IVTScrip™ mRNA-Human APOBEC3C, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA APOBEC3C
GTTS-WK21571MR IVTScrip™ mRNA-Human AOX1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA AOX1
GTTS-WK21852MR IVTScrip™ mRNA-Human ATG101, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ATG101
GTTS-WK9323MR IVTScrip™ mRNA-Human AASS, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA AASS
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW